Lund, Sweden

Tomas Leanderson

This inventor holds 2 USPTO granted patents and 1 EPO patent. Top assignee: Active Biotech Ab. Active years: 2003-2014.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Tomas Leanderson. Retrieved from https://idiyas.com/inventor/tomas-leanderson

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 50.0


Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Location History:

  • Malmoe, SE (2003)
  • Lund, SE (2014)

Company Filing History:


Years Active: 2003-2014

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations by Tomas Leanderson

Introduction

Tomas Leanderson is a notable inventor based in Lund, Sweden. He has made significant contributions to the field of therapeutic compounds, holding two patents that showcase his innovative approach to medical science.

Latest Patents

One of his latest patents is the "S100A9 interaction screening method." This method identifies compounds that can modulate the interaction of S100A9 with ligands. The process involves determining whether a candidate compound can influence the interaction of S100A9 with RAGE or TLR (Toll-like receptor). Additionally, it assesses whether a compound can bind to S100A9 in a way that disrupts its binding with RAGE or TLR, thereby identifying potential therapeutic uses.

Career Highlights

Tomas Leanderson is currently associated with Active Biotech AB, a company focused on developing innovative therapies. His work has been instrumental in advancing the understanding of immune modulation and therapeutic applications.

Collaborations

Some of his notable coworkers include Anders K Bjork and Gunnar Hedlund, who have collaborated with him on various projects within the company.

Conclusion

Tomas Leanderson's contributions to the field of therapeutic innovations highlight his expertise and commitment to advancing medical science. His patents reflect a deep understanding of complex biological interactions and their potential therapeutic implications.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…